The discovery and optimization of antibodies, whether through traditional methods or with the assistance of artificial intelligence, necessitates rapid and reliable data generation. Here we introduce ...

Antibody production can slow research to a crawl. As senior vice president of Biointron, Lei Shi works with scientists around the globe to optimize and expedite their antibody projects, from start to ...

Extracting therapeutic antibodies from biological systems requires stringent purification processes. To reduce costs and accelerate development, novel strategies are essential ...

Creative Biolabs streamlines bispecific antibody development by merging genetic engineering, cell-free expression, and high-throughput screening into a single, comprehensive pipeline.

The oPool + display platform combines technologies to make and test large numbers of antibodies at once. Antibodies are the critical targeting agents of the immune system and the crux of immune ...

For decades, antibodies have been one of the crown jewels of modern medicine—powerful molecules that can neutralize viruses, tame autoimmune diseases, and revolutionize cancer care. Yet despite their ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

The rapid advancements in cancer immunotherapy have positioned bispecific antibodies (BsAbs) and T-cell engagers (TCEs) as transformative therapeutic strategies. However, the development of these ...

The oPool+ display platform combines technologies to make and test large numbers of antibodies at once. Illinois researchers analyzed how antibodies bind to the influenza protein hemagglutinin.

Samsung Biologics expands Korea CRDMO lead with MCB and vector services Samsung Biologics widens CRDMO edge with new MCB and ...